Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control

NCT05743907 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: DA-2811
DRUG: Forxiga

Sponsor

Dong-A ST Co., Ltd.